- Display 15 Products per page
Published: December 23, 2014 | Price: $995.00 – $1,990.00
Assisted Living: Market Analysis The advancing age of the population makes long term care an important consideration for health marketers. This report covers assisted living, an important segment of the long term care industry that provides medical care and/or assistance with the activities of daily living (ADLs) to the elderly on an ongoing basis. This is a critical time for this segment of the market, not only a time of growth but also of increasing concern, as ongoing cost containment...Published: March 29, 2022 | Price: $3,750.00 – $7,500.00
The at-home IVD testing market is a growing market with much potential. This report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), analyzes at-home tests where the entire process is done at home. A sample is collected, and the results are provided in under one hour. This does not include self-collection at home and then sent to a laboratory where it can be analyzed. This report is segmented into three areas: Glucose Infectious disease Other...Published: June 6, 2023 | Price: $5,000.00 – $10,000.00
This new Kalorama Information report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023, examines a range of both at-home tests and home collection tests. The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods. [caption id="attachment_19849"...Published: April 15, 2021 | Price: $3,000.00 – $6,000.00
This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or...Published: January 15, 2005 | Price: $995.00 – $1,990.00
Despite the traditional notion that nothing therapeutic can be accomplished for the 1.5 million Americans with autism and the 2 million more throughout the world, there are pharmacologic approaches to the disease that are providing some help for patients and garnering revenues for drug companies. This Market Briefing reviews the market for drugs used in the treatment of autism and related disorers, including Antidepressants, Anti-Anxiety drugs, Anti-psychotics, Anti-convulsants, and CNS stimulants for ADHD-related symptoms, forecasting revenues through 2009 gloabally and...Published: September 29, 2021 | Price: $3,000.00 – $6,000.00
A considerable number of diagnostic tests are available or in development for the detection of autoimmune diseases. Because of this potentially large and growing market, vast opportunity exists for discovery and advancement in this arena. Competition within this market is expected to increase dramatically. However, in fledgling autoimmune IVD diagnostic testing markets, a golden opportunity exists to capitalize on new testing innovations without significant competition. In terms of test options, a substantial amount of overlap exists in the various autoimmune...Published: October 11, 2016 | Price: $3,360.00 – $6,720.00
Autoimmune IVD Testing Market This report provides important business planning information for in vitro diagnostic testing products, instruments and supplies used in the detection of autoimmune disease. The report includes market sizing and forecasts, regional markets, markets by type - including arthritis, thyroid, gastrological disease, SLE, and others. The report also details new innovations in testing and profiles companies in the market. The following companies are covered. Revenues, test product, and significant competitive moves are included: Thermo Fisher WerfenLife, Alere,...Published: July 27, 2020 | Price: $3,750.00 – $7,000.00
Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. Kalorama conducted a 2020 survey of laboratory instrument users in the United States, Canada and Europe (included in respondents are lab managers, lab directors, clinical...Published: August 19, 2022 | Price: $6,000.00 – $12,000.00
Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. Kalorama conducted a 2022 survey of laboratory instrument users in the United States, Canada and Europe (included in respondents are lab managers, lab directors, clinical...Published: August 26, 2014 | Price: $750.00 – $1,500.00
Big Data and Healthcare This Kalorama Information report, Big Data in Healthcare, outlines the key deals, mergers, consortia, and competitive events that have been formed in an attempt to meet the challenge of using healthcare data to enhance practice and boost revenues. Big data consists of the giant data pulls that emerge in every day use from manufacturers, healthcare organizations, governments, scientists and others. Those working with big data are seeking insights into the management of these large datasets. If...Published: August 17, 2017 | Price: $1,200.00 – $2,400.00
Big Data in Healthcare Big Data in Healthcare looks at selected current and future applications of Big Data within the healthcare industry, including usage in IT in in vitro diagnostics, personalized medicine, pharmaceutical industry, electronic medical records (EMR), mobile health (mHealth), and the health insurance industry. Big Data in Healthcare also presents information on the following Big Data developments: selected IVD industry IT/Big Data investments, selected IT innovations in molecular diagnostics, selected genomic tests for inherited diseases, selected digital imaging...Published: February 26, 2019 | Price:
Published: April 1, 2008 | Price: $995.00 – $7,000.00
In one sense, the opportunity for follow-on proteins is as good as ever. Some of the biggest-selling biologics developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, have lost patent protection or are set to lose patent protection in the US in 2007 and beyond. But there are also regulatory challenges to marketing follow-on biologics in the U.S. that companies will need to navigate to prosper. In this report, Biogenerics:...Published: June 7, 2013 | Price: $995.00 – $2,000.00
Computer diagnostics could offer opportunity for clinical laboratory professionals to add value to clinicians in diagnosing diseases. IT companies in collaboration with test vendors are developing computer software that complements the skills of human test interpretation. This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact. Bioinformatics-based testing has made a huge contribution to cancer diagnosis and therapy management. In infectious disease diagnostics it allows the detection of...Published: June 23, 2017 | Price: $1,200.00 – $2,400.00
What is the market for information technology systems used in the expanding market for next-generation sequencing (NGS)? What companies are in this space, who are they partnering with and what products are they offering? This report examines the important contribution made by information technology to the use of next-generation sequencing, and to the markets for systems and consumables. As part of its coverage, the report provides the following: Indirect Market for Bioinformatics (Including Influence on Overall NGS Market) Trends Company...